Preparing For Pot

ECONOMY: From Land to Law to Labs, Marijuana Sales Bring Changes, Opportunities

Inside a 1,000-square-foot room, yellow incandescent light filters down on leafy green marijuana plants in neat rows. Soon, plants and lighting will be added vertically — like a double-decker bus — so operator Outco can increase production more than twofold.

Tease photo

Cristiano R. Amon Named Qualcomm President

Amon will start his new role Jan. 4.

2017 Newsmakers: Win, Lose or Draw, Ionis Shows It Is a Top Competitor

2017 Newsmakers

In 2017, Carlsbad’s Ionis Pharmaceuticals basked in the success of a drug it developed to treat spinal muscular atrophy in infants.

Tease photo

Qualcomm's Board Rejects Broadcom Slate for Seats

The company affirmed that all 11 existing Qualcomm board members will stand for reelection at the March 6 annual meeting.

Tease photo

Roche Buys S.D. Drugmaker Ignyta for $1.7B

The pharma giant is betting on Ignyta's cancer drug, entrectinib, which is intended to treat patients with rare cancers.

Tease photo

DMV Gives Qualcomm the OK to Drive Autonomous Vehicles

Qualcomm has started tests of technology that will help autonomous vehicles navigate safely, though a spokesman said a driver is still in the seat.

Tease photo

At 125, San Diego Hardware Ages Well By Evolving Well

RETAIL: Family-Owned Biz Stays Nimble, Finds Niche, And Delivers Online

This month San Diego Hardware entered its 125th year of business, making it the seventh longest continuously operating business in the city.

Tease photo

Ionis and Biogen Expand Partnership

Carlsbad’s Ionis Pharmaceuticals and Biogen have expanded their collaboration to identify new drug candidates for the treatment of spinal muscular atrophy (SMA).

Signal Jammers Will be Made in S.D. as Part of Northrop Grumman's $23.2M Contract

The Pentagon is asking Northrop Grumman Corp. for more of its JCREW signal jammers.

LRAD Corp. Reports 24% Revenue Gain in Fiscal Year

Revenue for fiscal 2017 was $20.3 million and grew from $16.4 million in fiscal 2016.

Hedge Fund: Qualcomm's Bid for NXP Too Low

Elliott Management Corp., a hedge fund with a stake in NXP Semiconductors, says Qualcomm should pay $135 per share.

Tease photo

Ionis Earns $45M Licensing Fee for Huntington’s Disease Drug

The Carlsbad drugmaker has licensed what’s being called a groundbreaking treatment following promising early trial results.

Anzu Partners Closes $128M Fund, Opens La Jolla Office

Anzu Partners, a private equity and venture capital firm that recently closed a $128.4 million fund to invest in industrial technology companies, has opened an office in La Jolla.

GA-ASI Hosts Aerospace Accelerator Pitch Competition

Starburst brought young aerospace companies together with potential funding sources.

Adamis Applying for Approval of Product that Treats Opioid Overdose

the pharmaceuticals company has submitted an application to the U.S. Food and Drug Administration seeking to begin human testing of a drug and product combo for treating opioid overdoses.